Similar articles for PMID: 18375767

Year	Number of Results
1997	2
1999	1
2000	7
2001	3
2002	3
2003	7
2004	3
2005	6
2006	7
2007	7
2008	7
2009	3
2010	7
2011	5
2012	6
2013	4
2014	2
2015	2
2016	1
2017	3
2018	6
2019	3
2020	2
2021	2
2022	1
2024	0

1

Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene.

Tan-Wong SM, French JD, Proudfoot NJ, Brown MA. Tan-Wong SM, et al. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5160-5. doi: 10.1073/pnas.0801048105. Epub 2008 Mar 28. Proc Natl Acad Sci U S A. 2008. PMID: 18375767 Free PMC article.

2

Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.

Wen J, Li R, Lu Y, Shupnik MA. Wen J, et al. Oncogene. 2009 Jan 29;28(4):575-86. doi: 10.1038/onc.2008.405. Epub 2008 Nov 10. Oncogene. 2009. PMID: 18997820 Free PMC article.

3

Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene.

Hockings JK, Degner SC, Morgan SS, Kemp MQ, Romagnolo DF. Hockings JK, et al. Breast Cancer Res. 2008;10(2):R29. doi: 10.1186/bcr1987. Epub 2008 Mar 31. Breast Cancer Res. 2008. PMID: 18377656 Free PMC article.

4

Transcriptional repression of BRCA1 by aberrant cytosine methylation, histone hypoacetylation and chromatin condensation of the BRCA1 promoter.

Rice JC, Futscher BW. Rice JC, et al. Nucleic Acids Res. 2000 Sep 1;28(17):3233-9. doi: 10.1093/nar/28.17.3233. Nucleic Acids Res. 2000. PMID: 10954590 Free PMC article.

5

BRCA1 suppresses osteopontin-mediated breast cancer.

El-Tanani MK, Campbell FC, Crowe P, Erwin P, Harkin DP, Pharoah P, Ponder B, Rudland PS. El-Tanani MK, et al. J Biol Chem. 2006 Sep 8;281(36):26587-601. doi: 10.1074/jbc.M604403200. Epub 2006 Jun 28. J Biol Chem. 2006. PMID: 16807234 Free article.

6

Characterization of a negative transcriptional element in the BRCA1 promoter.

MacDonald G, Stramwasser M, Mueller CR. MacDonald G, et al. Breast Cancer Res. 2007;9(4):R49. doi: 10.1186/bcr1753. Breast Cancer Res. 2007. PMID: 17663789 Free PMC article.

7

Attenuation of RNA polymerase II pausing mitigates BRCA1-associated R-loop accumulation and tumorigenesis.

Zhang X, Chiang HC, Wang Y, Zhang C, Smith S, Zhao X, Nair SJ, Michalek J, Jatoi I, Lautner M, Oliver B, Wang H, Petit A, Soler T, Brunet J, Mateo F, Angel Pujana M, Poggi E, Chaldekas K, Isaacs C, Peshkin BN, Ochoa O, Chedin F, Theoharis C, Sun LZ, Curiel TJ, Elledge R, Jin VX, Hu Y, Li R. Zhang X, et al. Nat Commun. 2017 Jun 26;8:15908. doi: 10.1038/ncomms15908. Nat Commun. 2017. PMID: 28649985 Free PMC article.

8

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.

Jin W, Chen L, Chen Y, Xu SG, Di GH, Yin WJ, Wu J, Shao ZM. Jin W, et al. Breast Cancer Res Treat. 2010 Sep;123(2):359-73. doi: 10.1007/s10549-009-0652-2. Epub 2009 Nov 27. Breast Cancer Res Treat. 2010. PMID: 19943104

9

Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma.

Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, Pierantoni G, Croce CM, Fusco A. Baldassarre G, et al. Mol Cell Biol. 2003 Apr;23(7):2225-38. doi: 10.1128/MCB.23.7.2225-2238.2003. Mol Cell Biol. 2003. PMID: 12640109 Free PMC article.

10

Decreased expression of BRCA1 in SK-BR-3 cells is the result of aberrant activation of the GABP Beta promoter by an NRF-1-containing complex.

Thompson C, MacDonald G, Mueller CR. Thompson C, et al. Mol Cancer. 2011 May 24;10:62. doi: 10.1186/1476-4598-10-62. Mol Cancer. 2011. PMID: 21609478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year